Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.78M Buy
40,627
+3,353
+9% +$297K ﹤0.01% 1020
2025
Q4
$2.99M Buy
37,274
+3,256
+10% +$273K ﹤0.01% 1103
2025
Q3
$2.98M Buy
34,018
+28,665
+535% +$2.31M ﹤0.01% 1015
2025
Q2
$391K Sell
5,353
-545,694
-99% -$31.1M ﹤0.01% 1437
2025
Q1
$24.7M Buy
551,047
+61,796
+13% +$3.91M 0.01% 675
2024
Q4
$35.8M Buy
489,251
+64,256
+15% +$5.34M 0.01% 627
2024
Q3
$41.9M Buy
424,995
+296,897
+232% +$34.7M 0.02% 577
2024
Q2
$18.2M Buy
128,098
+120,641
+1,618% +$13.9M 0.01% 719
2024
Q1
$733K Sell
7,457
-22,469
-75% -$2.68M ﹤0.01% 1341
2023
Q4
$3.6M Sell
29,926
-59,780
-67% -$8.24M ﹤0.01% 1054
2023
Q3
$14.4M Sell
89,706
-935
-1% -$164K 0.01% 767
2023
Q2
$16.5M Sell
90,641
-18,861
-17% -$2.72M 0.01% 733
2023
Q1
$13.9M Buy
109,502
+37,502
+52% +$4.41M 0.01% 769
2022
Q4
$6.87M Hold
72,000
﹤0.01% 929
2022
Q3
$4.84M Buy
72,000
+70,741
+5,619% +$4.57M ﹤0.01% 987
2022
Q2
$69K Buy
+1,259
New +$73K ﹤0.01% 1504

Other funds holding ACLS

Amundi's ACLS Position: Q1 2026 in Review

Amundi increased its Axcelis (ACLS) stake by 9% in Q1 2026, buying an estimated $297K and bringing the position to 40,627 shares worth $3.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

Amundi first reported a position in ACLS in Q2 2022 and has held it in 16 quarters since. The position peaked at $41.9M in Q3 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Amundi held 40,627 shares of Axcelis worth $3.78M as of Q1 2026.
  • Amundi bought 3,353 Axcelis shares in Q1 2026, an estimated $297K.
  • Axcelis made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1020 holding.
  • Amundi first reported a position in Axcelis in Q2 2022 and has held it in 16 quarters since.
  • Amundi's Axcelis position peaked at $41.9M in Q3 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.